Starpax Biopharma Inc.
Follow- Proceeding
- CCAACompanies' Creditors Arrangement Act (RSC 1985, c. C-36, as amended)
- Court
- Superior Court of Québec · Commercial Division
- File
- 500-11-066112-257
Starpax Biopharma Inc. has been under CCAA protection in the Superior Court of Québec, Commercial Division, at Montréal since September 12, 2025, with Raymond Chabot Inc. acting as court-appointed controller. An interim order was granted on September 9, 2025, and on September 22 the Court approved a Sale and Investment Solicitation Process under which no break fee, expense reimbursement or similar payment is permitted. Phase 1 ran to a bid deadline of November 27, 2025; further bid deadlines of January 22, 2026 and February 13, 2026 are on the record. The controller's work has been dominated by preservation of the estate: property insurance, a temporary occupation agreement for the Starpax plant, essential utilities, IT and physical security, and protection of the company's patents and bacterial strain. The case remains active, with reporting to March 4, 2026.
25 earlier updates, back to 12 September 2025 — subscribers.
Debtor
Starpax Biopharma Inc.
Monitor
Raymond Chabot
Bench
| Judge | Court | On this docket | Cases on record |
|---|---|---|---|
| Justice Michelin | Superior Court of Québec | 7 orders, Sep 2025 – Mar 2026 | 9 cases on record |
| Justice Ouellet | Superior Court of Québec | 6 orders, Sep 2025 – Jun 2026 | 8 cases on record |
Counsel of record
| Party | Counsel | First seen | Source |
|---|---|---|---|
| CreditorFiducie Familiale Louis Audet | Fasken Martineau DuMoulin LLP | 4 Mar 2026 | Service list · 4 Mar 2026 |
| Creditorlocateur Me Maxime Champagne | Gowling WLG (Canada) LLP | 4 Mar 2026 | Service list · 4 Mar 2026 |
| CreditorMe Stéphane Hébert | Sylvestre Avocats Et Notaires | 4 Mar 2026 | Service list · 4 Mar 2026 |
| Priority class | Creditor | Amount | Source |
|---|---|---|---|
| Secured | Investissement Québec · in 99 casesTrustee's Creditor List, 'Amount Declared'; Amount Filed $0.00, Amount Admitted $0.00; Claim Status = Not Proven (N) — debtor: Starpax Biopharma Inc. · as of 19 Sep 2025 | $10.6M | 2025-09-19 Creditors' List |
Closed · the record states no distribution outcome.
The debtor’s own statement of its total assets and liabilities at filing is in the record — Subscribers
Cumulative receipts
$1.71M
As at 4 Mar 20262026-03-04 Third Report of the Monitor (in French)
| Date | Document | File |
|---|---|---|
2026-06-03 Order Ending of proceedings and Discharge of the Monitor (in French)
| PDF · Subscribers | |
| 2026-03-09 Approval and Vesting Order | PDF · Subscribers | |
2026-03-09 Radiation and Reduction Order (in French)
| PDF · Subscribers | |
2026-03-09 Second Amended and Restated Transition Order (in French)
| PDF · Subscribers | |
| 2026-03-04 Motion - Extension of stay and Approval of a transaction (in French) | PDF · Subscribers | |
2026-03-04 Service List
| PDF · Subscribers | |
2026-03-04 Third Report of the Monitor (in French)
| PDF · Subscribers | |
Second Notice of the postponed dates SISP (in French)
| PDF · Subscribers | |
2026-02-27 Order - Extension of stay (in French)
| PDF · Subscribers | |
Notice of the postponed deadline to select an offer (in French)
| PDF · Subscribers | |
2026-01-12 Order - Prolongation of stay (in French)
| PDF · Subscribers | |
| 2026-01-06 Motion - Extension of stay (in French) | PDF · Subscribers | |
2026-01-06 Second report of the Monitor
| PDF · Subscribers | |
500-11-066112-257 - Amended Procedures for the Sale and Investment Solicitation Process - October 9, 2025
| PDF · Subscribers | |
500-11-066112-257 - SISP Launch Notice with Appendix A - October 9, 2025
| PDF · Subscribers | |
2025-09-22 Amended and Restated Transition Order (in French)
| PDF · Subscribers | |
2025-09-22 SISP Order (in French)
| PDF · Subscribers | |
2025-09-19 Creditors' List
| PDF · Subscribers | |
2025-09-19 First report of the Monitor (in French)
| PDF · Subscribers | |
| 2025-09-17 Amended Motion for Amended and Restated Transition Order (in French) | PDF · Subscribers | |
| Starpax - Avis aux créanciers - Notice to creditors | PDF · Subscribers | |
2025-09-12 Transition Order and Initial Order (in french)
| PDF · Subscribers | |
Starpax - SISP Package
| PDF · Subscribers | |
2025-09-09 Order to appoint a Managing Judge (in French)
| PDF · Subscribers | |
2025-09-02 Minutes of the hearing (in French)
| PDF · Subscribers | |
2025-09-02 Motion for a Transition Order and Initial Order (in French)
| PDF · Subscribers | |
2025-09-02 Report of the Proposed Monitor (in French)
| PDF · Subscribers | |
Filing titles and dates are public, and so is each filing's own page. The figures read from them are for subscribers.
CiteProceedings., “Starpax Biopharma Inc.” (CCAA), Superior Court of Québec · Commercial Division. Retrieved 20 September 2026, https://proceedings.ca/case/starpax-biopharma-inc